S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

BeyondSpring Stock Forecast, Price & News

-0.23 (-6.55%)
(As of 01/21/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
1.37 million shs
Average Volume
848,149 shs
Market Capitalization
$128.27 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BYSI News and Ratings via Email

Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.

BeyondSpring logo

About BeyondSpring

BeyondSpring, Inc. engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. It operates through PRC and U.S. geographical segments. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.


BeyondSpring Cuts On-Third Of Its Workforce
January 12, 2022 |  finance.yahoo.com
BeyondSpring Announces Organizational Streamlining
January 11, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$180 thousand
Book Value
$2.21 per share


Net Income
$-60.97 million
Net Margins
Pretax Margin




Free Float
Market Cap
$128.27 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.85 out of 5 stars

Medical Sector

789th out of 1,419 stocks

Pharmaceutical Preparations Industry

380th out of 685 stocks

Analyst Opinion: 4.1Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

BeyondSpring (NASDAQ:BYSI) Frequently Asked Questions

Is BeyondSpring a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BeyondSpring in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BeyondSpring stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BYSI, but not buy additional shares or sell existing shares.
View analyst ratings for BeyondSpring
or view top-rated stocks.

How has BeyondSpring's stock been impacted by COVID-19?

BeyondSpring's stock was trading at $11.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BYSI stock has decreased by 71.1% and is now trading at $3.28.
View which stocks have been most impacted by COVID-19

When is BeyondSpring's next earnings date?

BeyondSpring is scheduled to release its next quarterly earnings announcement on Friday, April 29th 2022.
View our earnings forecast for BeyondSpring

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) released its earnings results on Wednesday, December, 29th. The company reported ($0.47) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.11. BeyondSpring had a negative trailing twelve-month return on equity of 118.78% and a negative net margin of 6,057.17%.
View BeyondSpring's earnings history

What price target have analysts set for BYSI?

6 brokers have issued 1 year price targets for BeyondSpring's stock. Their forecasts range from $5.00 to $65.00. On average, they expect BeyondSpring's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 814.6% from the stock's current price.
View analysts' price targets for BeyondSpring
or view top-rated stocks among Wall Street analysts.

Who are BeyondSpring's key executives?

BeyondSpring's management team includes the following people:
  • Lan Huang, Chairman & Chief Executive Officer
  • Richard J. Daly, Chief Operating Officer
  • Elizabeth Adkins Czerepak, Chief Financial Officer
  • G. Kenneth Lloyd, Chief Scientific Officer
  • Ramon W. Mohanlal, Director, Chief Medical Officer, Executive VP-R&D

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), CorMedix (CRMD) and Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

(BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

What is BeyondSpring's stock symbol?

BeyondSpring trades on the NASDAQ under the ticker symbol "BYSI."

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by a number of institutional and retail investors. Top institutional investors include Cutler Group LP (0.00%).

Which institutional investors are selling BeyondSpring stock?

BYSI stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.

How do I buy shares of BeyondSpring?

Shares of BYSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BeyondSpring's stock price today?

One share of BYSI stock can currently be purchased for approximately $3.28.

How much money does BeyondSpring make?

BeyondSpring has a market capitalization of $128.27 million and generates $180 thousand in revenue each year. The company earns $-60.97 million in net income (profit) each year or ($1.92) on an earnings per share basis.

How many employees does BeyondSpring have?

BeyondSpring employs 91 workers across the globe.

What is BeyondSpring's official website?

The official website for BeyondSpring is www.beyondspringpharma.com.

Where are BeyondSpring's headquarters?

BeyondSpring is headquartered at 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005.

How can I contact BeyondSpring?

BeyondSpring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The company can be reached via phone at (646) 305-6387, via email at [email protected], or via fax at 1-646-882-4228.

This page was last updated on 1/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.